Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions
Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions
批准号:
10620181
负责人:
Lu Qi
金额:
$66.36万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-01-01 至 2026-04-30
关键词:
AffectAutomobile DrivingBasal metabolic rateBiological MarkersBloodBlood GlucoseBlood PressureBody CompositionBody WeightBody Weight decreasedBody fatCarbohydratesCardiometabolic DiseaseClinicalCohort StudiesCollectionContinuous Glucose MonitorDesire for foodDevelopmentDietDietary CarbohydratesDietary FactorsDietary InterventionDual-Energy X-Ray AbsorptiometryEating BehaviorEnergy IntakeEnergy MetabolismFGF21 geneFastingFoodGlucoseGlycemic IndexGoalsGrantHeartHourHungerHyperglycemiaIndividualInflammationIntakeIntervention StudiesIntervention TrialIntrinsic factorLinkLipidsMacronutrients NutritionMapsMeasuresMediationNutritional StudyObesityParticipantPathway interactionsPlasmaPrecision HealthProductivityPublic HealthPublicationsQiRandomizedResearchResearch PersonnelResourcesRiskRisk FactorsSatiationSystemTestingTransducersUnited States National Institutes of HealthX-Ray Computed Tomographyadipokinescardiometabolic riskcardiometabolismcardiovascular disorder riskcohortdietarydoubly-labeled waterexperiencefibroblast growth factor 21ghrelinglucagon-like peptide 1gut microbiotaimprovedindividual variationinsightinsulin sensitivityinterestmetabolomemetabolomicsmicrobiota metabolitesnovelnutrition related geneticsnutritional genomicsobesity riskpost interventionprecision nutritionresponsetotal energy expenditure
中文摘要
摘要
过多的餐后血糖已成为调节能量摄入和导致肥胖的关键因素
和心脏代谢性疾病,最近的研究突出了日益增长的重要性和迫切需要测绘
精准营养和饮食干预中餐后血糖反应的个体差异。这个
拟议的系统研究旨在填补这一重大研究空白。我们的研究将建立在无与伦比的
来自三项饮食干预试验和队列的互补资源:OmniCarb试验、The Pound
失败的试验,以及精密健康研究(PHS)。我们将分析通常的禁食水平之间的联系
血浆代谢组和餐后代谢组学变化与餐后血糖反应
挑战测试(目标1);分析餐后动态变化(5周、6个月和24个月)
血糖指数(GI)和/或变化的饮食干预对血糖变异性相关代谢物的响应
碳水化合物摄入量(目标2)。我们还将研究餐后血糖变化的关系。
与变化相关的代谢物与食欲、能量摄入和消耗的变化(目标3)。此外,我们
将考察与餐后血糖变异性相关的时间序列和调节效应
饮食干预与心脏代谢变化之间的关系中的代谢物(目标4)。建议数
该项目很好地符合美国国立卫生研究院对营养遗传学和营养基因组学方法的特殊兴趣
研究(NOT-DK-19-019)‘和精准营养。我们的研究将提供对内在的
餐后血糖反应中个体变异性的决定因素,并对
开发新的精准饮食干预措施。我们的研究结果将对公众健康产生广泛的影响。
适用性和临床意义。
英文摘要
Abstract
Excessive postprandial glycemia has emerged as a key factor regulating energy intakes and driving obesity
and cardiometabolic diseases, and recent studies highlight the rising importance and urgent need of mapping
the individual variability of postprandial glycemic response in precision nutrition and diet interventions. The
proposed systems study aims to fill this significant research gap. Our study will build upon the unparalleled and
complementary resources from three diet intervention trials and cohort: The OmniCarb trial, The POUNDS
LOST trial, and The Precision Health Study (PHS). We will analyze associations of the usual levels of fasting
plasma metabolome and postprandial metabolomic changes with postprandial glycemic response in the meal
challenge tests (Aim 1); and analyze the dynamic changes (5 weeks, 6 and 24 months) in postprandial
glycemic variability-related metabolites in response to diet interventions varying in glycemic index (GI) and/or
carbohydrate intakes (Aim 2). We will also examine the relations of changes in postprandial glycemic
variability-related metabolites with changes in appetite, energy intake and expenditure (Aim 3). In addition, we
will examine the temporal sequence and mediation effects of postprandial glycemic variability-related
metabolites in the relation between diet interventions and cardiometabolic changes (Aim 4). The proposed
project aligns well with the special interest of NIH in ‘Nutrigenetics and Nutrigenomics Approaches for Nutrition
Research (NOT-DK-19-019)’ and precision nutrition. Our study will provide novel insights into the intrinsic
determinants of individual variability in postprandial glycemic response, and contribute significantly to the
development of novel precision diet interventions. The findings from our study will have wide public health
applicability and clinical implications.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank.
吸烟时机、遗传易感性和 2 型糖尿病发生风险:英国生物银行的一项队列研究。
DOI:
10.1111/dom.15603
发表时间:
2024
期刊:
Diabetes, obesity & metabolism
影响因子:
--
作者:
[Hu,Ying, Li,Xiang, Wang,Xuan, Ma,Hao, Zhou,Jian, Tang,Rui, Kou,Minghao, Heianza,Yoriko, Liang,Zhaoxia, Qi,Lu]
通讯作者:
Qi,Lu
Authors reply: Adherence to a healthy sleep pattern is associated with lower risks of all-cause, cardiovascular, and cancer-specific mortality.
作者回复:坚持健康的睡眠模式与降低全因死亡率、心血管死亡率和癌症死亡率相关。
DOI:
10.1111/joim.13475
发表时间:
2022
期刊:
Journal of internal medicine
影响因子:
11.1
作者:
[Qi,Lu]
通讯作者:
Qi,Lu
DOI:
10.1186/s12916-021-01942-5
发表时间:
2021-03-23
期刊:
BMC medicine
影响因子:
9.3
作者:
[Wang KS, Yu G, Xu C, Meng XH, Zhou J, Zheng C, Deng Z, Shang L, Liu R, Su S, Zhou X, Li Q, Li J, Wang J, Ma K, Qi J, Hu Z, Tang P, Deng J, Qiu X, Li BY, Shen WD, Quan RP, Yang JT, Huang LY, Xiao Y, Yang ZC, Li Z, Wang SC, Ren H, Liang C, Guo W, Li Y, Xiao H, Gu Y, Yun JP, Huang D, Song Z, Fan X, Chen L, Yan X, Li Z, Huang ZC, Huang J, Luttrell J, Zhang CY, Zhou W, Zhang K, Yi C, Wu C, Shen H, Wang YP, Xiao HM, Deng HW]
通讯作者:
Deng HW
DOI:
10.18632/aging.203926
发表时间:
2022-03-02
期刊:
Aging
影响因子:
--
作者:
[Zhao Q, Shen H, Liu J, Chiu CY, Su KJ, Tian Q, Kakhniashvili D, Qiu C, Zhao LJ, Luo Z, Deng HW]
通讯作者:
Deng HW
DOI:
10.1371/journal.pmed.1003767
发表时间:
2021-08
期刊:
PLoS medicine
影响因子:
15.8
作者:
[Li X, Wang M, Song Y, Ma H, Zhou T, Liang Z, Qi L]
通讯作者:
Qi L
共 19 条
Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions
-
批准号:9425969
-
项目类别:
-
资助金额:$67.99万
-
财政年份:2018
-
负责人:Lu Qi
-
依托单位:
Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions
-
批准号:10445545
-
项目类别:
-
资助金额:$68.45万
-
财政年份:2018
-
负责人:Lu Qi
-
依托单位:
Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions
-
批准号:10080726
-
项目类别:
-
资助金额:$64.21万
-
财政年份:2018
-
负责人:Lu Qi
-
依托单位:
Dissecting the impact of forced displacement on Type Two Diabetes
-
批准号:9791038
-
项目类别:
-
资助金额:$15.31万
-
财政年份:2018
-
负责人:Lu Qi
-
依托单位:
Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota
-
批准号:9185197
-
项目类别:
-
资助金额:$43.73万
-
财政年份:2014
-
负责人:Lu Qi
-
依托单位:
Genome-wide interactions with diet patterns on long-term weight change
-
批准号:8805017
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2014
-
负责人:Lu Qi
-
依托单位:
Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota
-
批准号:9535815
-
项目类别:
-
资助金额:$32.22万
-
财政年份:2014
-
负责人:Lu Qi
-
依托单位:
Genome-wide interactions with diet patterns on long-term weight change
-
批准号:9140769
-
项目类别:
-
资助金额:$21.87万
-
财政年份:2014
-
负责人:Lu Qi
-
依托单位:
Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota
-
批准号:9883471
-
项目类别:
-
资助金额:$65.15万
-
财政年份:2014
-
负责人:Lu Qi
-
依托单位:
Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota
-
批准号:10311104
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2014
-
负责人:Lu Qi
-
依托单位:
Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota
-
批准号:8761982
-
项目类别:
-
资助金额:$45.49万
-
财政年份:2014
-
负责人:Lu Qi
-
依托单位:
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
-
批准号:8676784
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2012
-
负责人:Lu Qi
-
依托单位:
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
-
批准号:9146639
-
项目类别:
-
资助金额:$44.69万
-
财政年份:2012
-
负责人:Lu Qi
-
依托单位:
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
-
批准号:9918889
-
项目类别:
-
资助金额:$64.64万
-
财政年份:2012
-
负责人:Lu Qi
-
依托单位:
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
-
批准号:10264786
-
项目类别:
-
资助金额:$64.57万
-
财政年份:2012
-
负责人:Lu Qi
-
依托单位:
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
-
批准号:8464087
-
项目类别:
-
资助金额:$48.2万
-
财政年份:2012
-
负责人:Lu Qi
-
依托单位:
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
-
批准号:9769001
-
项目类别:
-
资助金额:$64.46万
-
财政年份:2012
-
负责人:Lu Qi
-
依托单位:
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
-
批准号:8237351
-
项目类别:
-
资助金额:$51.11万
-
财政年份:2012
-
负责人:Lu Qi
-
依托单位:
Genetic Markers of CHD in Type 2 Diabetes
-
批准号:8232073
-
项目类别:
-
资助金额:$63.84万
-
财政年份:2003
-
负责人:Lu Qi
-
依托单位:
Genetic Markers of CHD in Type 2 Diabetes
-
批准号:8061673
-
项目类别:
-
资助金额:$63.57万
-
财政年份:2003
-
负责人:Lu Qi
-
依托单位:
海外基金